Tuesday, February 24, 2015 5:00:32 PM
I also think a lot is going to hinge on what (if anything) HEB can do in the next month leading up to their presentation of the USAMRIID work end of March to demonstrate corporate competence. Improving their corporate image and public perception cannot hurt in helping attract grant money (BARDA for example) and in greasing the skids some for the next run at approval by the FDA.
And they have to at least look like they are doing something to re-vitalize and clarify their production capacity. They may have the 'wonder drug' (or at least a wonder drug) - but they have to be able to produce it in quantity and quality in order for it to be useful and not just some really cool scientific oddity.
“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy
Recent HEB News
- TMX Group Equity Financing Statistics - April 2023 • PR Newswire (Canada) • 05/08/2023 01:00:00 PM
- Statistiques de financement par actions du Groupe TMX pour avril 2023 • PR Newswire (Canada) • 05/08/2023 01:00:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM